wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38814615-1C6AEF93-A1D4-4EF3-B426-50237A594937
Q38814615-1C6AEF93-A1D4-4EF3-B426-50237A594937
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38814615-1C6AEF93-A1D4-4EF3-B426-50237A594937
Do patient access schemes for high-cost cancer drugs deliver value to society?-lessons from the NHS Cancer Drugs Fund.
P2860
Q38814615-1C6AEF93-A1D4-4EF3-B426-50237A594937
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38814615-1C6AEF93-A1D4-4EF3-B426-50237A594937
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8722b158aae16af978aaedd9236ba6f383db1d06
P2860
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).